Medical Care
Global Depression Drugs Market Research Report 2025
- May 05, 25
- ID: 228785
- Pages: 86
- Figures: 85
- Views: 7
The global market for Depression Drugs was valued at US$ 18130 million in the year 2024 and is projected to reach a revised size of US$ 22080 million by 2031, growing at a CAGR of 2.9% during the forecast period.
Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.
Global Depression Drugs key players include Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, etc. Global top five manufacturers hold a share over 35%.
North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share about 50%.
In terms of product, SSRIs is the largest segment, with a share over 45%. And in terms of application, the largest application is Hospitals, followed by Clinics, etc.
This report aims to provide a comprehensive presentation of the global market for Depression Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Depression Drugs.
The Depression Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Depression Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Depression Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Intellipharmaceutics
Pfizer
Eli Lilly
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Kanghong Pharma
HUAHAI
Segment by Type
SSRIs
SNRIs
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Depression Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.
Global Depression Drugs key players include Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, etc. Global top five manufacturers hold a share over 35%.
North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share about 50%.
In terms of product, SSRIs is the largest segment, with a share over 45%. And in terms of application, the largest application is Hospitals, followed by Clinics, etc.
This report aims to provide a comprehensive presentation of the global market for Depression Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Depression Drugs.
The Depression Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Depression Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Depression Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Intellipharmaceutics
Pfizer
Eli Lilly
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Kanghong Pharma
HUAHAI
Segment by Type
SSRIs
SNRIs
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Depression Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Depression Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 SSRIs
1.2.3 SNRIs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Depression Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Depression Drugs Market Perspective (2020-2031)
2.2 Global Depression Drugs Growth Trends by Region
2.2.1 Global Depression Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Depression Drugs Historic Market Size by Region (2020-2025)
2.2.3 Depression Drugs Forecasted Market Size by Region (2026-2031)
2.3 Depression Drugs Market Dynamics
2.3.1 Depression Drugs Industry Trends
2.3.2 Depression Drugs Market Drivers
2.3.3 Depression Drugs Market Challenges
2.3.4 Depression Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Depression Drugs Players by Revenue
3.1.1 Global Top Depression Drugs Players by Revenue (2020-2025)
3.1.2 Global Depression Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Depression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Depression Drugs Revenue
3.4 Global Depression Drugs Market Concentration Ratio
3.4.1 Global Depression Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Depression Drugs Revenue in 2024
3.5 Global Key Players of Depression Drugs Head office and Area Served
3.6 Global Key Players of Depression Drugs, Product and Application
3.7 Global Key Players of Depression Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Depression Drugs Breakdown Data by Type
4.1 Global Depression Drugs Historic Market Size by Type (2020-2025)
4.2 Global Depression Drugs Forecasted Market Size by Type (2026-2031)
5 Depression Drugs Breakdown Data by Application
5.1 Global Depression Drugs Historic Market Size by Application (2020-2025)
5.2 Global Depression Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Depression Drugs Market Size (2020-2031)
6.2 North America Depression Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Depression Drugs Market Size by Country (2020-2025)
6.4 North America Depression Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Depression Drugs Market Size (2020-2031)
7.2 Europe Depression Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Depression Drugs Market Size by Country (2020-2025)
7.4 Europe Depression Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Depression Drugs Market Size (2020-2031)
8.2 Asia-Pacific Depression Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Depression Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Depression Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Depression Drugs Market Size (2020-2031)
9.2 Latin America Depression Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Depression Drugs Market Size by Country (2020-2025)
9.4 Latin America Depression Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Depression Drugs Market Size (2020-2031)
10.2 Middle East & Africa Depression Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Depression Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Depression Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intellipharmaceutics
11.1.1 Intellipharmaceutics Company Details
11.1.2 Intellipharmaceutics Business Overview
11.1.3 Intellipharmaceutics Depression Drugs Introduction
11.1.4 Intellipharmaceutics Revenue in Depression Drugs Business (2020-2025)
11.1.5 Intellipharmaceutics Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Depression Drugs Introduction
11.2.4 Pfizer Revenue in Depression Drugs Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Depression Drugs Introduction
11.3.4 Eli Lilly Revenue in Depression Drugs Business (2020-2025)
11.3.5 Eli Lilly Recent Development
11.4 Astrazeneca
11.4.1 Astrazeneca Company Details
11.4.2 Astrazeneca Business Overview
11.4.3 Astrazeneca Depression Drugs Introduction
11.4.4 Astrazeneca Revenue in Depression Drugs Business (2020-2025)
11.4.5 Astrazeneca Recent Development
11.5 Lundbeck
11.5.1 Lundbeck Company Details
11.5.2 Lundbeck Business Overview
11.5.3 Lundbeck Depression Drugs Introduction
11.5.4 Lundbeck Revenue in Depression Drugs Business (2020-2025)
11.5.5 Lundbeck Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Depression Drugs Introduction
11.6.4 Allergan Revenue in Depression Drugs Business (2020-2025)
11.6.5 Allergan Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Depression Drugs Introduction
11.7.4 GSK Revenue in Depression Drugs Business (2020-2025)
11.7.5 GSK Recent Development
11.8 Otsuka Pharmaceutical
11.8.1 Otsuka Pharmaceutical Company Details
11.8.2 Otsuka Pharmaceutical Business Overview
11.8.3 Otsuka Pharmaceutical Depression Drugs Introduction
11.8.4 Otsuka Pharmaceutical Revenue in Depression Drugs Business (2020-2025)
11.8.5 Otsuka Pharmaceutical Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Depression Drugs Introduction
11.9.4 Takeda Revenue in Depression Drugs Business (2020-2025)
11.9.5 Takeda Recent Development
11.10 NHU Group
11.10.1 NHU Group Company Details
11.10.2 NHU Group Business Overview
11.10.3 NHU Group Depression Drugs Introduction
11.10.4 NHU Group Revenue in Depression Drugs Business (2020-2025)
11.10.5 NHU Group Recent Development
11.11 Shionogi
11.11.1 Shionogi Company Details
11.11.2 Shionogi Business Overview
11.11.3 Shionogi Depression Drugs Introduction
11.11.4 Shionogi Revenue in Depression Drugs Business (2020-2025)
11.11.5 Shionogi Recent Development
11.12 APOTEX
11.12.1 APOTEX Company Details
11.12.2 APOTEX Business Overview
11.12.3 APOTEX Depression Drugs Introduction
11.12.4 APOTEX Revenue in Depression Drugs Business (2020-2025)
11.12.5 APOTEX Recent Development
11.13 Kanghong Pharma
11.13.1 Kanghong Pharma Company Details
11.13.2 Kanghong Pharma Business Overview
11.13.3 Kanghong Pharma Depression Drugs Introduction
11.13.4 Kanghong Pharma Revenue in Depression Drugs Business (2020-2025)
11.13.5 Kanghong Pharma Recent Development
11.14 HUAHAI
11.14.1 HUAHAI Company Details
11.14.2 HUAHAI Business Overview
11.14.3 HUAHAI Depression Drugs Introduction
11.14.4 HUAHAI Revenue in Depression Drugs Business (2020-2025)
11.14.5 HUAHAI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Depression Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 SSRIs
1.2.3 SNRIs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Depression Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Depression Drugs Market Perspective (2020-2031)
2.2 Global Depression Drugs Growth Trends by Region
2.2.1 Global Depression Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Depression Drugs Historic Market Size by Region (2020-2025)
2.2.3 Depression Drugs Forecasted Market Size by Region (2026-2031)
2.3 Depression Drugs Market Dynamics
2.3.1 Depression Drugs Industry Trends
2.3.2 Depression Drugs Market Drivers
2.3.3 Depression Drugs Market Challenges
2.3.4 Depression Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Depression Drugs Players by Revenue
3.1.1 Global Top Depression Drugs Players by Revenue (2020-2025)
3.1.2 Global Depression Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Depression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Depression Drugs Revenue
3.4 Global Depression Drugs Market Concentration Ratio
3.4.1 Global Depression Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Depression Drugs Revenue in 2024
3.5 Global Key Players of Depression Drugs Head office and Area Served
3.6 Global Key Players of Depression Drugs, Product and Application
3.7 Global Key Players of Depression Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Depression Drugs Breakdown Data by Type
4.1 Global Depression Drugs Historic Market Size by Type (2020-2025)
4.2 Global Depression Drugs Forecasted Market Size by Type (2026-2031)
5 Depression Drugs Breakdown Data by Application
5.1 Global Depression Drugs Historic Market Size by Application (2020-2025)
5.2 Global Depression Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Depression Drugs Market Size (2020-2031)
6.2 North America Depression Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Depression Drugs Market Size by Country (2020-2025)
6.4 North America Depression Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Depression Drugs Market Size (2020-2031)
7.2 Europe Depression Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Depression Drugs Market Size by Country (2020-2025)
7.4 Europe Depression Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Depression Drugs Market Size (2020-2031)
8.2 Asia-Pacific Depression Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Depression Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Depression Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Depression Drugs Market Size (2020-2031)
9.2 Latin America Depression Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Depression Drugs Market Size by Country (2020-2025)
9.4 Latin America Depression Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Depression Drugs Market Size (2020-2031)
10.2 Middle East & Africa Depression Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Depression Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Depression Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intellipharmaceutics
11.1.1 Intellipharmaceutics Company Details
11.1.2 Intellipharmaceutics Business Overview
11.1.3 Intellipharmaceutics Depression Drugs Introduction
11.1.4 Intellipharmaceutics Revenue in Depression Drugs Business (2020-2025)
11.1.5 Intellipharmaceutics Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Depression Drugs Introduction
11.2.4 Pfizer Revenue in Depression Drugs Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Depression Drugs Introduction
11.3.4 Eli Lilly Revenue in Depression Drugs Business (2020-2025)
11.3.5 Eli Lilly Recent Development
11.4 Astrazeneca
11.4.1 Astrazeneca Company Details
11.4.2 Astrazeneca Business Overview
11.4.3 Astrazeneca Depression Drugs Introduction
11.4.4 Astrazeneca Revenue in Depression Drugs Business (2020-2025)
11.4.5 Astrazeneca Recent Development
11.5 Lundbeck
11.5.1 Lundbeck Company Details
11.5.2 Lundbeck Business Overview
11.5.3 Lundbeck Depression Drugs Introduction
11.5.4 Lundbeck Revenue in Depression Drugs Business (2020-2025)
11.5.5 Lundbeck Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Depression Drugs Introduction
11.6.4 Allergan Revenue in Depression Drugs Business (2020-2025)
11.6.5 Allergan Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Depression Drugs Introduction
11.7.4 GSK Revenue in Depression Drugs Business (2020-2025)
11.7.5 GSK Recent Development
11.8 Otsuka Pharmaceutical
11.8.1 Otsuka Pharmaceutical Company Details
11.8.2 Otsuka Pharmaceutical Business Overview
11.8.3 Otsuka Pharmaceutical Depression Drugs Introduction
11.8.4 Otsuka Pharmaceutical Revenue in Depression Drugs Business (2020-2025)
11.8.5 Otsuka Pharmaceutical Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Depression Drugs Introduction
11.9.4 Takeda Revenue in Depression Drugs Business (2020-2025)
11.9.5 Takeda Recent Development
11.10 NHU Group
11.10.1 NHU Group Company Details
11.10.2 NHU Group Business Overview
11.10.3 NHU Group Depression Drugs Introduction
11.10.4 NHU Group Revenue in Depression Drugs Business (2020-2025)
11.10.5 NHU Group Recent Development
11.11 Shionogi
11.11.1 Shionogi Company Details
11.11.2 Shionogi Business Overview
11.11.3 Shionogi Depression Drugs Introduction
11.11.4 Shionogi Revenue in Depression Drugs Business (2020-2025)
11.11.5 Shionogi Recent Development
11.12 APOTEX
11.12.1 APOTEX Company Details
11.12.2 APOTEX Business Overview
11.12.3 APOTEX Depression Drugs Introduction
11.12.4 APOTEX Revenue in Depression Drugs Business (2020-2025)
11.12.5 APOTEX Recent Development
11.13 Kanghong Pharma
11.13.1 Kanghong Pharma Company Details
11.13.2 Kanghong Pharma Business Overview
11.13.3 Kanghong Pharma Depression Drugs Introduction
11.13.4 Kanghong Pharma Revenue in Depression Drugs Business (2020-2025)
11.13.5 Kanghong Pharma Recent Development
11.14 HUAHAI
11.14.1 HUAHAI Company Details
11.14.2 HUAHAI Business Overview
11.14.3 HUAHAI Depression Drugs Introduction
11.14.4 HUAHAI Revenue in Depression Drugs Business (2020-2025)
11.14.5 HUAHAI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Depression Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of SSRIs
Table 3. Key Players of SNRIs
Table 4. Key Players of Others
Table 5. Global Depression Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Depression Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Depression Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Depression Drugs Market Share by Region (2020-2025)
Table 9. Global Depression Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Depression Drugs Market Share by Region (2026-2031)
Table 11. Depression Drugs Market Trends
Table 12. Depression Drugs Market Drivers
Table 13. Depression Drugs Market Challenges
Table 14. Depression Drugs Market Restraints
Table 15. Global Depression Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Depression Drugs Market Share by Players (2020-2025)
Table 17. Global Top Depression Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Drugs as of 2024)
Table 18. Ranking of Global Top Depression Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Depression Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Depression Drugs, Headquarters and Area Served
Table 21. Global Key Players of Depression Drugs, Product and Application
Table 22. Global Key Players of Depression Drugs, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Depression Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Depression Drugs Revenue Market Share by Type (2020-2025)
Table 26. Global Depression Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Depression Drugs Revenue Market Share by Type (2026-2031)
Table 28. Global Depression Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Depression Drugs Revenue Market Share by Application (2020-2025)
Table 30. Global Depression Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Depression Drugs Revenue Market Share by Application (2026-2031)
Table 32. North America Depression Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Depression Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Depression Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Depression Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Depression Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Depression Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Depression Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Depression Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Depression Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Depression Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Depression Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Depression Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Depression Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Depression Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Depression Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Intellipharmaceutics Company Details
Table 48. Intellipharmaceutics Business Overview
Table 49. Intellipharmaceutics Depression Drugs Product
Table 50. Intellipharmaceutics Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 51. Intellipharmaceutics Recent Development
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer Depression Drugs Product
Table 55. Pfizer Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Eli Lilly Company Details
Table 58. Eli Lilly Business Overview
Table 59. Eli Lilly Depression Drugs Product
Table 60. Eli Lilly Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 61. Eli Lilly Recent Development
Table 62. Astrazeneca Company Details
Table 63. Astrazeneca Business Overview
Table 64. Astrazeneca Depression Drugs Product
Table 65. Astrazeneca Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 66. Astrazeneca Recent Development
Table 67. Lundbeck Company Details
Table 68. Lundbeck Business Overview
Table 69. Lundbeck Depression Drugs Product
Table 70. Lundbeck Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 71. Lundbeck Recent Development
Table 72. Allergan Company Details
Table 73. Allergan Business Overview
Table 74. Allergan Depression Drugs Product
Table 75. Allergan Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 76. Allergan Recent Development
Table 77. GSK Company Details
Table 78. GSK Business Overview
Table 79. GSK Depression Drugs Product
Table 80. GSK Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 81. GSK Recent Development
Table 82. Otsuka Pharmaceutical Company Details
Table 83. Otsuka Pharmaceutical Business Overview
Table 84. Otsuka Pharmaceutical Depression Drugs Product
Table 85. Otsuka Pharmaceutical Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 86. Otsuka Pharmaceutical Recent Development
Table 87. Takeda Company Details
Table 88. Takeda Business Overview
Table 89. Takeda Depression Drugs Product
Table 90. Takeda Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 91. Takeda Recent Development
Table 92. NHU Group Company Details
Table 93. NHU Group Business Overview
Table 94. NHU Group Depression Drugs Product
Table 95. NHU Group Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 96. NHU Group Recent Development
Table 97. Shionogi Company Details
Table 98. Shionogi Business Overview
Table 99. Shionogi Depression Drugs Product
Table 100. Shionogi Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 101. Shionogi Recent Development
Table 102. APOTEX Company Details
Table 103. APOTEX Business Overview
Table 104. APOTEX Depression Drugs Product
Table 105. APOTEX Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 106. APOTEX Recent Development
Table 107. Kanghong Pharma Company Details
Table 108. Kanghong Pharma Business Overview
Table 109. Kanghong Pharma Depression Drugs Product
Table 110. Kanghong Pharma Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 111. Kanghong Pharma Recent Development
Table 112. HUAHAI Company Details
Table 113. HUAHAI Business Overview
Table 114. HUAHAI Depression Drugs Product
Table 115. HUAHAI Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 116. HUAHAI Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Depression Drugs Picture
Figure 2. Global Depression Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Depression Drugs Market Share by Type: 2024 VS 2031
Figure 4. SSRIs Features
Figure 5. SNRIs Features
Figure 6. Others Features
Figure 7. Global Depression Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Depression Drugs Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Depression Drugs Report Years Considered
Figure 13. Global Depression Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Depression Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Depression Drugs Market Share by Region: 2024 VS 2031
Figure 16. Global Depression Drugs Market Share by Players in 2024
Figure 17. Global Top Depression Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Drugs as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Depression Drugs Revenue in 2024
Figure 19. North America Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Depression Drugs Market Share by Country (2020-2031)
Figure 21. United States Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Depression Drugs Market Share by Country (2020-2031)
Figure 25. Germany Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Depression Drugs Market Share by Region (2020-2031)
Figure 33. China Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Depression Drugs Market Share by Country (2020-2031)
Figure 41. Mexico Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Depression Drugs Market Share by Country (2020-2031)
Figure 45. Turkey Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Intellipharmaceutics Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 50. Eli Lilly Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 51. Astrazeneca Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 52. Lundbeck Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 53. Allergan Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 54. GSK Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 55. Otsuka Pharmaceutical Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 56. Takeda Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 57. NHU Group Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 58. Shionogi Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 59. APOTEX Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 60. Kanghong Pharma Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 61. HUAHAI Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Depression Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of SSRIs
Table 3. Key Players of SNRIs
Table 4. Key Players of Others
Table 5. Global Depression Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Depression Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Depression Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Depression Drugs Market Share by Region (2020-2025)
Table 9. Global Depression Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Depression Drugs Market Share by Region (2026-2031)
Table 11. Depression Drugs Market Trends
Table 12. Depression Drugs Market Drivers
Table 13. Depression Drugs Market Challenges
Table 14. Depression Drugs Market Restraints
Table 15. Global Depression Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Depression Drugs Market Share by Players (2020-2025)
Table 17. Global Top Depression Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Drugs as of 2024)
Table 18. Ranking of Global Top Depression Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Depression Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Depression Drugs, Headquarters and Area Served
Table 21. Global Key Players of Depression Drugs, Product and Application
Table 22. Global Key Players of Depression Drugs, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Depression Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Depression Drugs Revenue Market Share by Type (2020-2025)
Table 26. Global Depression Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Depression Drugs Revenue Market Share by Type (2026-2031)
Table 28. Global Depression Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Depression Drugs Revenue Market Share by Application (2020-2025)
Table 30. Global Depression Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Depression Drugs Revenue Market Share by Application (2026-2031)
Table 32. North America Depression Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Depression Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Depression Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Depression Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Depression Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Depression Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Depression Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Depression Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Depression Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Depression Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Depression Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Depression Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Depression Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Depression Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Depression Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 47. Intellipharmaceutics Company Details
Table 48. Intellipharmaceutics Business Overview
Table 49. Intellipharmaceutics Depression Drugs Product
Table 50. Intellipharmaceutics Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 51. Intellipharmaceutics Recent Development
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer Depression Drugs Product
Table 55. Pfizer Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Eli Lilly Company Details
Table 58. Eli Lilly Business Overview
Table 59. Eli Lilly Depression Drugs Product
Table 60. Eli Lilly Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 61. Eli Lilly Recent Development
Table 62. Astrazeneca Company Details
Table 63. Astrazeneca Business Overview
Table 64. Astrazeneca Depression Drugs Product
Table 65. Astrazeneca Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 66. Astrazeneca Recent Development
Table 67. Lundbeck Company Details
Table 68. Lundbeck Business Overview
Table 69. Lundbeck Depression Drugs Product
Table 70. Lundbeck Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 71. Lundbeck Recent Development
Table 72. Allergan Company Details
Table 73. Allergan Business Overview
Table 74. Allergan Depression Drugs Product
Table 75. Allergan Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 76. Allergan Recent Development
Table 77. GSK Company Details
Table 78. GSK Business Overview
Table 79. GSK Depression Drugs Product
Table 80. GSK Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 81. GSK Recent Development
Table 82. Otsuka Pharmaceutical Company Details
Table 83. Otsuka Pharmaceutical Business Overview
Table 84. Otsuka Pharmaceutical Depression Drugs Product
Table 85. Otsuka Pharmaceutical Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 86. Otsuka Pharmaceutical Recent Development
Table 87. Takeda Company Details
Table 88. Takeda Business Overview
Table 89. Takeda Depression Drugs Product
Table 90. Takeda Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 91. Takeda Recent Development
Table 92. NHU Group Company Details
Table 93. NHU Group Business Overview
Table 94. NHU Group Depression Drugs Product
Table 95. NHU Group Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 96. NHU Group Recent Development
Table 97. Shionogi Company Details
Table 98. Shionogi Business Overview
Table 99. Shionogi Depression Drugs Product
Table 100. Shionogi Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 101. Shionogi Recent Development
Table 102. APOTEX Company Details
Table 103. APOTEX Business Overview
Table 104. APOTEX Depression Drugs Product
Table 105. APOTEX Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 106. APOTEX Recent Development
Table 107. Kanghong Pharma Company Details
Table 108. Kanghong Pharma Business Overview
Table 109. Kanghong Pharma Depression Drugs Product
Table 110. Kanghong Pharma Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 111. Kanghong Pharma Recent Development
Table 112. HUAHAI Company Details
Table 113. HUAHAI Business Overview
Table 114. HUAHAI Depression Drugs Product
Table 115. HUAHAI Revenue in Depression Drugs Business (2020-2025) & (US$ Million)
Table 116. HUAHAI Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Depression Drugs Picture
Figure 2. Global Depression Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Depression Drugs Market Share by Type: 2024 VS 2031
Figure 4. SSRIs Features
Figure 5. SNRIs Features
Figure 6. Others Features
Figure 7. Global Depression Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Depression Drugs Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Depression Drugs Report Years Considered
Figure 13. Global Depression Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Depression Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Depression Drugs Market Share by Region: 2024 VS 2031
Figure 16. Global Depression Drugs Market Share by Players in 2024
Figure 17. Global Top Depression Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Drugs as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Depression Drugs Revenue in 2024
Figure 19. North America Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Depression Drugs Market Share by Country (2020-2031)
Figure 21. United States Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Depression Drugs Market Share by Country (2020-2031)
Figure 25. Germany Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Depression Drugs Market Share by Region (2020-2031)
Figure 33. China Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Depression Drugs Market Share by Country (2020-2031)
Figure 41. Mexico Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Depression Drugs Market Share by Country (2020-2031)
Figure 45. Turkey Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Depression Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Intellipharmaceutics Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 50. Eli Lilly Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 51. Astrazeneca Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 52. Lundbeck Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 53. Allergan Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 54. GSK Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 55. Otsuka Pharmaceutical Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 56. Takeda Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 57. NHU Group Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 58. Shionogi Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 59. APOTEX Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 60. Kanghong Pharma Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 61. HUAHAI Revenue Growth Rate in Depression Drugs Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232